We thus designed CAR-T cells targeting B7–H3 and, after finding that IL-7 is also highly expressed in chordoma samples, coupled sequences to secrete IL-7 from B7–H3 CAR-T cells, thereby enhancing the anti-tumor and sustained killing ability of CAR-T cells. The gene discussed is IL7; the disease is chordoma.